283 related articles for article (PubMed ID: 30112638)
1. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
2. The true prognosis of resected distal cholangiocarcinoma.
Courtin-Tanguy L; Rayar M; Bergeat D; Merdrignac A; Harnoy Y; Boudjema K; Meunier B; Sulpice L
J Surg Oncol; 2016 Apr; 113(5):575-80. PubMed ID: 26776934
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
[TBL] [Abstract][Full Text] [Related]
4. Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma.
Courtin-Tanguy L; Turrini O; Bergeat D; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
HPB (Oxford); 2018 May; 20(5):405-410. PubMed ID: 29208352
[TBL] [Abstract][Full Text] [Related]
5. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
[TBL] [Abstract][Full Text] [Related]
6. Orotate phosphoribosyltransferase as a predictor of benefit from S-1 adjuvant chemotherapy for cholangiocarcinoma patients.
Akahoshi K; Ban D; Kuboki R; Oba A; Ono H; Mitsunori Y; Kudo A; Tanaka S; Tanabe M
J Gastroenterol Hepatol; 2019 Jun; 34(6):1108-1115. PubMed ID: 30242888
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
8. Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
Oncology; 2019; 96(6):290-298. PubMed ID: 30909286
[TBL] [Abstract][Full Text] [Related]
9. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M; Belkouz A; van der Geest LG; van Gulik TM; van Hooft JE; de Meijer VE; Haj Mohammad N; de Reuver PR; Verheij J; de Vos-Geelen J; Wilmink JW; Groot Koerkamp B; Klümpen HJ; Besselink MG;
Acta Oncol; 2019 Jul; 58(7):1048-1055. PubMed ID: 30907207
[No Abstract] [Full Text] [Related]
10. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
[TBL] [Abstract][Full Text] [Related]
11. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after pancreatoduodenectomy for ampullary cancer: The influence of the histological subtypes and comparison with the other periampullary neoplasms.
Nappo G; Galvanin J; Gentile D; Capretti G; Pulvirenti A; Bozzarelli S; Rimassa L; Spaggiari P; Carrara S; Petitti T; Gavazzi F; Zerbi A
Pancreatology; 2021 Aug; 21(5):950-956. PubMed ID: 33795194
[TBL] [Abstract][Full Text] [Related]
13. Robotic versus open pancreaticoduodenectomy for distal cholangiocarcinoma: a multicenter propensity score-matched study.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
Surg Endosc; 2022 Nov; 36(11):8237-8248. PubMed ID: 35534733
[TBL] [Abstract][Full Text] [Related]
14. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
[TBL] [Abstract][Full Text] [Related]
15. Impact of intraoperative blood transfusion on short and long term outcomes after curative hepatectomy for intrahepatic cholangiocarcinoma: a propensity score matching analysis by the AFC-IHCC study group.
Gómez-Gavara C; Doussot A; Lim C; Salloum C; Lahat E; Fuks D; Farges O; Regimbeau JM; Azoulay D
HPB (Oxford); 2017 May; 19(5):411-420. PubMed ID: 28122668
[TBL] [Abstract][Full Text] [Related]
16. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
[TBL] [Abstract][Full Text] [Related]
17. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
18. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy.
Sugawara T; Rodriguez Franco S; Sherman S; Kirsch MJ; Colborn K; Ishida J; Grandi S; Al-Musawi MH; Gleisner A; Schulick RD; Del Chiaro M
JAMA Oncol; 2023 Mar; 9(3):316-323. PubMed ID: 36480190
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
Wirasorn K; Ngamprasertchai T; Khuntikeo N; Pakkhem A; Ungarereevittaya P; Chindaprasirt J; Sookprasert A
J Gastroenterol Hepatol; 2013 Dec; 28(12):1885-91. PubMed ID: 23829232
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
Kamarajah SK; Bednar F; Cho CS; Nathan H
Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]